Aytu BioPharma
Balance Sheet
Last updated:
The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Aytu BioPharma's balance sheet done over the years? Its assets were worth $118,095,000 last year, which is less than in the previous period. 77% of Aytu BioPharma’s total assets is currently financed by debt. Its liabilities reached the amount of $90,379,000, which means an decrease by -7% compared compared to last year.
Debt to Assets
| 2015 | 18226806 | 2.61M | 14.32% |
|---|---|---|---|
| 2016 | 24343007 | 14.25M | 58.57% |
| 2017 | 14998517 | 10.99M | 73.33% |
| 2018 | 21060093 | 7.63M | 36.26% |
| 2019 | 34721391 | 27.63M | 79.59% |
| 2020 | 152836330 | 57.82M | 37.83% |
| 2021 | 265668000 | 128.1M | 48.22% |
| 2022 | 137623000 | 91.53M | 66.51% |
| 2023 | 136463000 | 97.10M | 71.16% |
| 2024 | 118095000 | 90.37M | 76.53% |
AYTU Balance Sheet (2015 – 2024)
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets: | ||||||||||
Cash and cash equivalents | 20.00M | 22.98M | 19.36M | 49.64M | 48.08M | 11.04M | 7.01M | 802.32K | 8.05M | 7.35M |
Short term investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.04M | 0 |
Net receivables | 23.61M | 28.93M | 21.71M | 28.17M | 5.17M | 1.74M | 578.78K | 528.03K | 162.42K | 157.05K |
Inventory | 12.63M | 11.99M | 10.84M | 16.33M | 9.99M | 1.44M | 1.33M | 1.31M | 524.70K | 39.44K |
Other current assets | 5.63M | 8.91M | 633K | 1.03M | 5.74M | 1.20M | 540.00K | 385.97K | 337.54K | 534.29K |
Total current assets | 61.89M | 72.83M | 59.92M | 105.23M | 74.96M | 15.43M | 9.47M | 3.02M | 10.12M | 8.08M |
Non-current assets: | ||||||||||
Property, Plant and Equipment | 1.52M | 3.86M | 6.29M | 8.70M | 892.60K | 203.73K | 219K | 647.25K | 231.43K | 30K |
Goodwill | 0 | 0 | 0 | 65.80M | 28.09M | 0 | 0 | 238.42K | 221K | 74K |
Intangible assets | 52.45M | 58.97M | 70.63M | 85.46M | 48.85M | 19.08M | 11.36M | 11.08M | 13.55M | 9.69M |
Long term investments | 0 | -1.37M | 0 | -10.90M | -1.80M | 0 | 0 | 0 | 0 | -41.42K |
Other non-current assets | 2.22M | 792K | 766K | 465K | 32.98K | 2.2K | 4.71K | 2.88K | 216.35K | 339.82K |
Total non-current assets | 56.20M | 63.63M | 77.69M | 160.43M | 77.87M | 19.28M | 11.58M | 11.96M | 14.22M | 10.14M |
Total assets | 118.09M | 136.46M | 137.62M | 265.66M | 152.83M | 34.72M | 21.06M | 14.99M | 24.34M | 18.22M |
Liabilities | ||||||||||
| Current liabilities: | ||||||||||
Accounts payable | ||||||||||
Deferred revenue | 0 | 46.79M | 0 | 57.23M | 339.33K | 0 | 0 | 0 | 0 | 85.71K |
Short term debt | 4.25M | 85K | 3.90M | 25.54M | 1.28M | 0 | 0 | 0 | 0 | 0 |
Total current liabilities | 62.22M | 69.01M | 64.44M | 109.43M | 28.30M | 5.37M | 3.39M | 3.61M | 10.10M | 1.47M |
| Non-current liabilities: | ||||||||||
Long term debt | 10.87M | 14.71M | 14.27M | 2.80M | 725.37K | 0 | 0 | 0 | 0 | 0 |
Deferred tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other non-current liabilities | 17.27M | 13.37M | 12.81M | 15.85M | 28.78M | 22.26M | 4.24M | 7.38M | 4.15M | 664K |
Total non-current liabilities | 28.15M | 28.09M | 27.08M | 18.66M | 29.51M | 22.26M | 4.24M | 7.38M | 4.15M | 1.13M |
Total liabilities | 90.37M | 97.10M | 91.53M | 128.1M | 57.82M | 27.63M | 7.63M | 10.99M | 14.25M | 2.61M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |